QJM

Association Between PCSK9 Inhibitor Use and Risk of Incident Heart Failure in Patients With Dyslipidemia

By Jheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, Hsuan-Yuan Chang, Yu-Min Lin

Cohort study of 40,098 peopleInterventions

1 year

The paper

Jheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, Hsuan-Yuan Chang, Yu-Min Lin

Chi Mei Medical Center

QJM, 10 Sep 2026

doi.org/10.1093/qjmed/hcag235 PubMed 42720614

The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Internal and Emergency Medicine4 Oct 2026
ARNI links to lower osteoporosis risk in heart failure
medRxiv4 Oct 2026
Inflammatory burden is linked to incident heart failure
medRxiv4 Oct 2026
Social context predicts heart risks despite normal biomarkers